CANBERRA, Australia — Australians fighting the asbestos-related cancer, mesothelioma, will soon be able to buy lifesaving drugs at a fraction of the retail cost. Opdivoand and Yervoy help activate patients’ immune systems to recognize and attack unresectable malignant mesothelioma, which cannot be treated surgically. The medications will from July 1 be listed on the federal government’s Pharmaceutical Benefits Scheme, reducing treatment to about […]
The post Discounted Cancer Drug Set To Save Lives In Australia first appeared on The Florida Star | The Georgia Star.
